Salima Lydia Brillman, MD
Psychiatry · Sunnyvale
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Has dropped Medicare — you would pay privately
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Brillman’s office at (408) 734-2800 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$578,775
Pharmacies billed $578,775 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 860) in 2024. At or below the middle of the specialty; the typical psychiatry & neurology clinician is at 0%.
478 generic and fewer than 11 brand-name prescriptions · $578,775 in drug cost · 68 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rytary | Parkinson's | 182 | $195,025 | $1,072 |
| Nuplazid | Parkinson's psychosis | 27 | $133,018 | $4,927 |
| Gocovri | None | 40 | $72,944 | $1,824 |
| Nourianz | None | 23 | $45,998 | $2,000 |
| Neupro | None | 25 | $20,600 | $824 |
See all 26 drugs
| Rytary | Parkinson's | 182 | $195,025 | $1,072 |
| Nuplazid | Parkinson's psychosis | 27 | $133,018 | $4,927 |
| Gocovri | None | 40 | $72,944 | $1,824 |
| Nourianz | None | 23 | $45,998 | $2,000 |
| Neupro | None | 25 | $20,600 | $824 |
| Qulipta | None | 14 | $17,221 | $1,230 |
| Ongentys | None | 15 | $9,782 | $652 |
| Rasagiline Mesylate | None | 56 | $6,998 | $125 |
| Diclofenac | None | 15 | $2,556 | $170 |
| Quetiapine | None | 37 | $1,354 | $37 |
| Rivastigmine | None | 31 | $1,101 | $36 |
| Escitalopram | None | 29 | $523 | $18 |
| Nortriptyline | None | 12 | $483 | $40 |
| Carbidopa-Levodopa | None | 15 | $427 | $28 |
| Amantadine | None | 11 | $425 | $39 |
| Gabapentin | None | 29 | $337 | $12 |
| Sumatriptan | None | 12 | $329 | $27 |
| Fludrocortisone Acetate | None | 12 | $242 | $20 |
| Donepezil | None | 25 | $221 | $9 |
| Mirtazapine | None | 12 | $209 | $17 |
| Zolpidem | None | 11 | $192 | $17 |
| Lorazepam | None | 12 | $180 | $15 |
| Clonazepam | None | 20 | $150 | $7 |
| Hydralazine | None | 11 | $111 | $10 |
| Amlodipine Besylate | None | 11 | $61 | $6 |
| Sertraline | None | 20 | $34 | $2 |
Year by year
| 2024 | 860 | 46 | 0% (0) | None | $578,775 |
| 2023 | 840 | 42 | 0% (0) | 44% | $660,116 |
| 2022 | 648 | 39 | 0% (0) | 44% | $421,791 |
| 2021 | 658 | 37 | 0% (0) | None | $706,939 |
| 2020 | 745 | 36 | 0% (0) | 46% | $811,358 |
| 2019 | 661 | 35 | 0% (0) | 38% | $475,595 |
| 2018 | 1,163 | 181 | 0% (0) | 42% | $1,198,301 |
| 2017 | 3,349 | 301 | None | None | $2,682,316 |
| 2016 | 1,372 | 291 | None | 38% | $1,561,280 |
| 2015 | 1,727 | 276 | None | 42% | $1,894,592 |
| 2014 | 4,007 | 604 | None | 28% | $420,426 |
| 2013 | 5,527 | 738 | 0% (12) | 31% | $417,317 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Rytary | Parkinson's | 165 | $181,516 | $1,100 |
| Nuplazid | Parkinson's psychosis | 30 | $153,650 | $5,122 |
| Gocovri | None | 55 | $88,362 | $1,607 |
| Inbrija | None | 14 | $50,322 | $3,594 |
| Nourianz | None | 22 | $49,765 | $2,262 |
| Ongentys | None | 18 | $15,745 | $875 |
| Rasagiline Mesylate | None | 45 | $11,403 | $253 |
| Rivastigmine | None | 30 | $2,294 | $76 |
| Midodrine | None | 13 | $1,897 | $146 |
| Quetiapine | None | 53 | $1,285 | $24 |
| Pyridostigmine | None | 11 | $1,021 | $93 |
| Carbidopa-Levodopa | None | 40 | $892 | $22 |
| Selegiline | None | 12 | $838 | $70 |
| Mirtazapine | None | 18 | $799 | $44 |
| Escitalopram | None | 35 | $618 | $18 |
| Lorazepam | None | 14 | $564 | $40 |
| Fludrocortisone Acetate | None | 22 | $394 | $18 |
| Donepezil | None | 27 | $389 | $14 |
| Nortriptyline | None | 14 | $279 | $20 |
| Gabapentin | None | 16 | $179 | $11 |
| Ondansetron | None | 13 | $74 | $6 |
| Clonazepam | None | 15 | $67 | $4 |
2022: 16 drugs
| Rytary | Parkinson's | 134 | $131,275 | $980 |
| Nuplazid | Parkinson's psychosis | 22 | $101,151 | $4,598 |
| Gocovri | None | 36 | $69,627 | $1,934 |
| Rasagiline Mesylate | None | 47 | $20,489 | $436 |
| Neupro | None | 18 | $14,732 | $818 |
| Myrbetriq | None | 15 | $11,455 | $764 |
| Carbidopa-Levodopa | None | 31 | $1,798 | $58 |
| Midodrine | None | 11 | $1,121 | $102 |
| Gabapentin | None | 21 | $554 | $26 |
| Quetiapine | None | 34 | $387 | $11 |
| Fludrocortisone Acetate | None | 16 | $329 | $21 |
| Escitalopram | None | 31 | $195 | $6 |
| Mirtazapine | None | 11 | $183 | $17 |
| Trazodone | None | 13 | $178 | $14 |
| Clonazepam | None | 11 | $57 | $5 |
| Lorazepam | None | 11 | $35 | $3 |
2021: 20 drugs
| Nuplazid | Parkinson's psychosis | 46 | $184,028 | $4,001 |
| Rytary | Parkinson's | 105 | $85,857 | $818 |
| Inbrija | None | 19 | $60,661 | $3,193 |
| Gocovri | None | 19 | $35,128 | $1,849 |
| Neupro | None | 13 | $9,652 | $742 |
| Rasagiline Mesylate | None | 35 | $9,626 | $275 |
| Myrbetriq | None | 16 | $7,133 | $446 |
| Midodrine | None | 20 | $1,662 | $83 |
| Carbidopa-Levodopa | None | 12 | $981 | $82 |
| Carbamazepine | None | 11 | $607 | $55 |
| Mirtazapine | None | 16 | $581 | $36 |
| Quetiapine | None | 32 | $427 | $13 |
| Fludrocortisone Acetate | None | 16 | $296 | $19 |
| Gabapentin | None | 23 | $171 | $7 |
| Escitalopram | None | 18 | $120 | $7 |
| Chlorhexidine Gluconate | None | 11 | $90 | $8 |
| Clonazepam | None | 14 | $77 | $6 |
| Ondansetron | None | 13 | $49 | $4 |
| Lorazepam | None | 16 | $28 | $2 |
| Clozapine | None | 12 | $21 | $2 |
2020: 19 drugs
| Northera | None | 16 | $276,380 | $17,274 |
| Nuplazid | Parkinson's psychosis | 65 | $240,920 | $3,706 |
| Inbrija | None | 30 | $75,542 | $2,518 |
| Rytary | Parkinson's | 122 | $71,454 | $586 |
| Neupro | None | 21 | $15,210 | $724 |
| Xadago | None | 13 | $12,007 | $924 |
| Myrbetriq | None | 11 | $7,009 | $637 |
| Rivastigmine | None | 22 | $6,572 | $299 |
| Pramipexole Er | None | 14 | $5,816 | $415 |
| Rasagiline Mesylate | None | 19 | $5,371 | $283 |
| Midodrine | None | 29 | $4,137 | $143 |
| Divalproex | None | 23 | $1,509 | $66 |
| Carbidopa-Levodopa | None | 11 | $1,491 | $136 |
| Quetiapine | None | 71 | $1,043 | $15 |
| Pramipexole Dihydrochloride | None | 11 | $763 | $69 |
| Memantine | None | 11 | $554 | $50 |
| Mirtazapine | None | 14 | $289 | $21 |
| Escitalopram | None | 24 | $189 | $8 |
| Ondansetron | None | 19 | $49 | $3 |
2019: 19 drugs
| Nuplazid | Parkinson's psychosis | 44 | $147,156 | $3,344 |
| Rytary | Parkinson's | 70 | $52,496 | $750 |
| Neupro | None | 36 | $26,764 | $743 |
| Gocovri | None | 18 | $25,011 | $1,389 |
| Xadago | None | 14 | $11,029 | $788 |
| Rivastigmine | None | 17 | $4,587 | $270 |
| Rasagiline Mesylate | None | 12 | $4,119 | $343 |
| Carbidopa-Levodopa | None | 33 | $1,904 | $58 |
| Midodrine | None | 19 | $1,367 | $72 |
| Duloxetine | None | 12 | $1,294 | $108 |
| Ropinirole Er | None | 12 | $1,255 | $105 |
| Quetiapine | None | 36 | $626 | $17 |
| Diclofenac | None | 14 | $561 | $40 |
| Escitalopram | None | 36 | $393 | $11 |
| Fludrocortisone Acetate | None | 11 | $343 | $31 |
| Clonazepam | None | 29 | $340 | $12 |
| Mirtazapine | None | 13 | $338 | $26 |
| Buspirone | None | 20 | $257 | $13 |
| Gabapentin | None | 13 | $75 | $6 |
2018: 27 drugs
| Northera | None | 24 | $357,913 | $14,913 |
| Apokyn | None | 14 | $276,675 | $19,763 |
| Nuplazid | Parkinson's psychosis | 60 | $177,067 | $2,951 |
| Rytary | Parkinson's | 184 | $124,475 | $676 |
| Rasagiline Mesylate | None | 64 | $56,780 | $887 |
| Gocovri | None | 24 | $43,909 | $1,830 |
| Neupro | None | 41 | $35,635 | $869 |
| Xadago | None | 17 | $20,091 | $1,182 |
| Rivastigmine | None | 34 | $11,582 | $341 |
| Carbidopa-Levodopa | None | 185 | $9,309 | $50 |
| Carbidopa-Levodopa-Entacapone | None | 13 | $8,623 | $663 |
| Amantadine | None | 47 | $5,925 | $126 |
| Entacapone | None | 22 | $5,817 | $264 |
| Carbidopa-Levodopa Er | None | 52 | $3,628 | $70 |
| Memantine | None | 34 | $2,272 | $67 |
| Rivastigmine | None | 13 | $2,005 | $154 |
| Ropinirole Er | None | 11 | $1,685 | $153 |
| Pramipexole Dihydrochloride | None | 29 | $1,101 | $38 |
| Fludrocortisone Acetate | None | 22 | $629 | $29 |
| Midodrine | None | 16 | $620 | $39 |
| Mirtazapine | None | 33 | $493 | $15 |
| Escitalopram | None | 13 | $377 | $29 |
| Quetiapine | None | 14 | $347 | $25 |
| Clonazepam | None | 16 | $290 | $18 |
| Donepezil | None | 17 | $248 | $15 |
| Gabapentin | None | 14 | $161 | $11 |
| Atorvastatin | None | 13 | $112 | $9 |
2017: 42 drugs
| Northera | None | 83 | $1,113,472 | $13,415 |
| Apokyn | None | 18 | $319,883 | $17,771 |
| Rytary | Parkinson's | 388 | $302,890 | $781 |
| Nuplazid | Parkinson's psychosis | 110 | $253,024 | $2,300 |
| Rasagiline Mesylate | None | 194 | $163,719 | $844 |
| Neupro | None | 110 | $88,812 | $807 |
| Azilect | None | 64 | $79,908 | $1,249 |
| Rivastigmine | None | 96 | $45,940 | $479 |
| Carbidopa-Levodopa | None | 670 | $39,192 | $58 |
| Carbidopa-Levodopa-Entacapone | None | 76 | $35,808 | $471 |
| Exelon | None | 19 | $19,705 | $1,037 |
| Xadago | None | 27 | $19,047 | $705 |
| Amantadine | None | 141 | $17,001 | $121 |
| Carbidopa-Levodopa Er | None | 184 | $14,698 | $80 |
| Pramipexole Er | None | 28 | $14,518 | $518 |
| Carbidopa | None | 13 | $13,653 | $1,050 |
| Ropinirole Er | None | 63 | $10,138 | $161 |
| Entacapone | None | 21 | $9,621 | $458 |
| Selegiline | None | 53 | $5,526 | $104 |
| Midodrine | None | 58 | $5,123 | $88 |
| Namenda Xr | None | 11 | $4,262 | $387 |
| Rivastigmine | None | 30 | $4,113 | $137 |
| Memantine | None | 34 | $3,506 | $103 |
| Pramipexole Dihydrochloride | None | 69 | $3,128 | $45 |
| Fludrocortisone Acetate | None | 50 | $1,977 | $40 |
| Propranolol Hcl Er | None | 23 | $1,445 | $63 |
| Duloxetine | None | 14 | $1,196 | $85 |
| Escitalopram | None | 75 | $1,195 | $16 |
| Quetiapine | None | 64 | $1,032 | $16 |
| Clonazepam | None | 57 | $981 | $17 |
| Mirtazapine | None | 52 | $836 | $16 |
| Primidone | None | 11 | $678 | $62 |
| Ropinirole | None | 22 | $636 | $29 |
| Clozapine | None | 64 | $575 | $9 |
| Donepezil | None | 37 | $522 | $14 |
| Buspirone | None | 48 | $440 | $9 |
| Gabapentin | None | 30 | $426 | $14 |
| Sertraline | None | 15 | $369 | $25 |
| Trazodone | None | 14 | $336 | $24 |
| Citalopram Hbr | None | 28 | $222 | $8 |
| Propranolol | None | 11 | $175 | $16 |
| Lorazepam | None | 11 | $86 | $8 |
2016: 28 drugs
| Northera | None | 95 | $1,001,777 | $10,545 |
| Azilect | None | 150 | $133,193 | $888 |
| Rytary | Parkinson's | 92 | $75,955 | $826 |
| Nuplazid | Parkinson's psychosis | 21 | $46,247 | $2,202 |
| Neupro | None | 50 | $38,058 | $761 |
| Carbidopa | None | 18 | $15,751 | $875 |
| Rivastigmine | None | 45 | $13,525 | $301 |
| Carbidopa-Levodopa | None | 323 | $11,082 | $34 |
| Carbidopa-Levodopa-Entacapone | None | 21 | $7,702 | $367 |
| Amantadine | None | 53 | $5,163 | $97 |
| Carbidopa-Levodopa Er | None | 56 | $2,788 | $50 |
| Selegiline | None | 19 | $2,498 | $131 |
| Ropinirole Er | None | 19 | $2,469 | $130 |
| Memantine | None | 16 | $1,976 | $124 |
| Midodrine | None | 28 | $1,853 | $66 |
| Propranolol Hcl Er | None | 12 | $682 | $57 |
| Quetiapine | None | 26 | $617 | $24 |
| Mirtazapine | None | 21 | $587 | $28 |
| Fludrocortisone Acetate | None | 13 | $561 | $43 |
| Pramipexole Dihydrochloride | None | 16 | $515 | $32 |
| Escitalopram | None | 24 | $400 | $17 |
| Donepezil | None | 32 | $394 | $12 |
| Primidone | None | 12 | $372 | $31 |
| Clonazepam | None | 19 | $302 | $16 |
| Alprazolam | None | 11 | $239 | $22 |
| Sertraline | None | 12 | $150 | $13 |
| Gabapentin | None | 12 | $144 | $12 |
| Buspirone | None | 17 | $116 | $7 |
2015: 29 drugs
| Northera | None | 146 | $1,166,854 | $7,992 |
| Xenazine | None | 26 | $160,020 | $6,155 |
| Azilect | None | 174 | $148,271 | $852 |
| Rytary | Parkinson's | 95 | $61,741 | $650 |
| Neupro | None | 52 | $38,961 | $749 |
| Exelon | None | 31 | $18,600 | $600 |
| Carbidopa-Levodopa-Entacapone | None | 56 | $16,301 | $291 |
| Namenda Xr | None | 36 | $15,145 | $421 |
| Carbidopa-Levodopa | None | 316 | $11,621 | $37 |
| Namenda | None | 26 | $9,623 | $370 |
| Entacapone | None | 19 | $6,588 | $347 |
| Ropinirole Er | None | 32 | $3,692 | $115 |
| Midodrine | None | 44 | $3,141 | $71 |
| Carbidopa-Levodopa Er | None | 60 | $2,716 | $45 |
| Propranolol Hcl Er | None | 30 | $1,754 | $58 |
| Memantine | None | 15 | $1,552 | $103 |
| Selegiline | None | 13 | $1,426 | $110 |
| Amantadine | None | 21 | $1,388 | $66 |
| Quetiapine | None | 54 | $1,047 | $19 |
| Primidone | None | 63 | $770 | $12 |
| Fludrocortisone Acetate | None | 17 | $662 | $39 |
| Donepezil | None | 57 | $464 | $8 |
| Clozapine | None | 15 | $412 | $27 |
| Gabapentin | None | 37 | $340 | $9 |
| Clonazepam | None | 47 | $249 | $5 |
| Escitalopram | None | 27 | $211 | $8 |
| Mirtazapine | None | 16 | $198 | $12 |
| Sertraline | None | 22 | $170 | $8 |
| Ropinirole | None | 14 | $149 | $11 |
2014: 53 drugs
| Namenda | 231 | $68,513 | $297 |
| Azilect | 70 | $38,795 | $554 |
| Exelon | 87 | $35,675 | $410 |
| Namenda Xr | 65 | $23,357 | $359 |
| Lyrica | 99 | $23,063 | $233 |
| Carbidopa-Levodopa-Entacapone | 76 | $22,712 | $299 |
| Entacapone | 56 | $19,384 | $346 |
| Neupro | 25 | $12,547 | $502 |
| Lodosyn | 14 | $12,408 | $886 |
| Carbidopa-Levodopa | 498 | $11,217 | $23 |
| Duloxetine | 36 | $9,953 | $276 |
| Amantadine | 80 | $8,954 | $112 |
| Linzess | 31 | $7,434 | $240 |
| Crestor | 38 | $7,161 | $188 |
| Vimpat | 11 | $6,255 | $569 |
| Carbidopa-Levodopa Er | 137 | $5,393 | $39 |
| Ropinirole | 48 | $4,935 | $103 |
| Divalproex Sodium Er | 24 | $4,688 | $195 |
| Lidocaine | 20 | $4,415 | $221 |
| Propranolol Hcl Er | 47 | $3,722 | $79 |
| Levetiracetam | 153 | $3,709 | $24 |
| Cymbalta | 11 | $3,705 | $337 |
| Gabapentin | 416 | $3,396 | $8 |
| Donepezil | 246 | $3,258 | $13 |
| Pramipexole Dihydrochloride | 46 | $2,192 | $48 |
| Phenytoin Sodium Extended | 93 | $1,640 | $18 |
| Tegretol Xr | 19 | $1,284 | $68 |
| Primidone | 128 | $1,217 | $10 |
| Quetiapine | 120 | $1,086 | $9 |
| Escitalopram | 54 | $847 | $16 |
| Dilantin | 14 | $692 | $49 |
| Carbamazepine | 24 | $684 | $29 |
| Clopidogrel | 49 | $622 | $13 |
| Mirtazapine | 40 | $508 | $13 |
| Topiramate | 83 | $496 | $6 |
| Risperidone | 42 | $488 | $12 |
| Oxcarbazepine | 19 | $484 | $25 |
| Lamotrigine | 50 | $453 | $9 |
| Divalproex | 26 | $384 | $15 |
| Clonazepam | 68 | $356 | $5 |
| Propranolol | 36 | $314 | $9 |
| Paroxetine | 42 | $311 | $7 |
| Trihexyphenidyl | 47 | $270 | $6 |
| Meclizine | 11 | $180 | $16 |
| Alprazolam | 65 | $177 | $3 |
| Citalopram Hbr | 33 | $173 | $5 |
| Phenobarbital | 12 | $172 | $14 |
| Sertraline | 25 | $157 | $6 |
| Simvastatin | 33 | $156 | $5 |
| Baclofen | 21 | $105 | $5 |
| Ibuprofen | 22 | $98 | $4 |
| Folic Acid | 28 | $83 | $3 |
| Amitriptyline | 12 | $25 | $2 |
2013: 60 drugs
| Namenda | 278 | $73,668 | $265 |
| Exelon | 116 | $37,106 | $320 |
| Azilect | 68 | $30,517 | $449 |
| Cymbalta | 103 | $29,949 | $291 |
| Lyrica | 140 | $29,837 | $213 |
| Carbidopa-Levodopa-Entacapone | 69 | $23,700 | $343 |
| Carbidopa-Levodopa | 643 | $15,713 | $24 |
| Entacapone | 42 | $15,259 | $363 |
| Amantadine | 140 | $14,263 | $102 |
| Vimpat | 29 | $13,966 | $482 |
| Levetiracetam | 267 | $8,093 | $30 |
| Lodosyn | 20 | $7,786 | $389 |
| Gabapentin | 604 | $7,761 | $13 |
| Carbidopa-Levodopa Er | 203 | $7,747 | $38 |
| Ropinirole | 68 | $6,303 | $93 |
| Neupro | 14 | $5,474 | $391 |
| Divalproex Sodium Er | 68 | $5,399 | $79 |
| Crestor | 27 | $4,935 | $183 |
| Rivastigmine | 29 | $4,825 | $166 |
| Donepezil | 286 | $3,854 | $13 |
| Escitalopram | 109 | $3,665 | $34 |
| Lidoderm | 14 | $3,070 | $219 |
| Quetiapine | 138 | $2,780 | $20 |
| Pramipexole Dihydrochloride | 63 | $2,688 | $43 |
| Seroquel Xr | 12 | $2,434 | $203 |
| Phenytoin Sodium Extended | 119 | $2,121 | $18 |
| Tegretol Xr | 30 | $2,118 | $71 |
| Lamotrigine | 123 | $1,936 | $16 |
| Propranolol | 107 | $1,566 | $15 |
| Clopidogrel | 76 | $1,440 | $19 |
| Midodrine | 24 | $1,342 | $56 |
| Primidone | 107 | $1,009 | $9 |
| Oxcarbazepine | 20 | $835 | $42 |
| Mirtazapine | 95 | $817 | $9 |
| Pyridostigmine | 19 | $779 | $41 |
| Risperidone | 42 | $777 | $18 |
| Voltaren | 17 | $726 | $43 |
| Topiramate | 99 | $667 | $7 |
| Divalproex | 50 | $653 | $13 |
| Dilantin | 11 | $601 | $55 |
| Alprazolam | 116 | $492 | $4 |
| Paroxetine | 94 | $485 | $5 |
| Citalopram Hbr | 58 | $462 | $8 |
| Atorvastatin | 26 | $457 | $18 |
| Benztropine Mesylate | 23 | $358 | $16 |
| Clonazepam | 88 | $306 | $3 |
| Carbamazepine | 14 | $300 | $21 |
| Simvastatin | 70 | $286 | $4 |
| Baclofen | 55 | $269 | $5 |
| Trihexyphenidyl | 50 | $257 | $5 |
| Pantoprazole | 12 | $172 | $14 |
| Sumatriptan | 11 | $161 | $15 |
| Temazepam | 17 | $151 | $9 |
| Omeprazole | 11 | $143 | $13 |
| Sertraline | 17 | $123 | $7 |
| Amitriptyline | 30 | $117 | $4 |
| Folic Acid | 37 | $114 | $3 |
| Trazodone | 12 | $84 | $7 |
| Ibuprofen | 28 | $68 | $2 |
| Furosemide | 11 | $34 | $3 |
Money from drug and device companies
$277,985 in 2025
| 2025 | 9 | 293 | $245,043 | $277,985 |
| 2024 | 12 | 208 | $157,094 | $184,885 |
| 2023 | 12 | 149 | $123,092 | $134,484 |
| 2022 | 13 | 195 | $140,233 | $163,426 |
| 2021 | 13 | 160 | $158,984 | $171,067 |
| 2020 | 14 | 168 | $131,007 | $140,565 |
| 2019 | 15 | 455 | $263,393 | $325,131 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| MDD US Operations | Apokyn | $116,219 | 122 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $46,480 | 38 payments
|
| Neurocrine BioSciences | Ingrezza | $40,401 | 49 payments
|
| Abbvie | Vyalev | $40,187 | 44 payments
|
| Amneal Pharmaceuticals | Crexont | $20,588 | 22 payments
|
| Merz Pharmaceuticals | Inbrija | $11,255 | 11 payments
|
See all 293 published payments
| Neurocrine BioSciences | Consulting · 2025-12-18 | None | $2,700 |
| Neurocrine BioSciences | Consulting · 2025-12-18 | None | $2,700 |
| Abbvie | Paid to speak or teach · 2025-12-17 | Vyalev | $4,550 |
| Abbvie | Paid to speak or teach · 2025-12-17 | Vyalev | $3,250 |
| Merz Pharmaceuticals | Paid to speak or teach · 2025-12-16 | Inbrija | $440 |
| Merz Pharmaceuticals | Meals · 2025-12-15 | Inbrija | $23 |
| MDD US Operations | Honoraria · 2025-12-04 | None | $500 |
| Abbvie | Paid to speak or teach · 2025-12-03 | Vyalev | $1,950 |
| Abbvie | Meals · 2025-12-02 | Vyalev | $109 |
| Abbvie | Travel · 2025-11-28 | Vyalev | $239 |
| Abbvie | Meals · 2025-11-25 | Vyalev | $16 |
| Neurocrine BioSciences | Meals · 2025-11-25 | Ingrezza | $21 |
| Abbvie | Travel · 2025-11-19 | Vyalev | $750 |
| Abbvie | Meals · 2025-11-19 | Vyalev | $118 |
| Abbvie | Paid to speak or teach · 2025-11-19 | Vyalev | $3,250 |
| Amneal Pharmaceuticals | Meals · 2025-11-17 | Crexont | $10 |
| Abbvie | Travel · 2025-11-15 | Vyalev | $311 |
| Amneal Pharmaceuticals | Honoraria · 2025-11-06 | Crexont | $4,973 |
| Abbvie | Paid to speak or teach · 2025-11-05 | Vyalev | $4,550 |
| MDD US Operations | Travel · 2025-11-05 | None | $455 |
| MDD US Operations | Honoraria · 2025-11-05 | None | $5,780 |
| Amneal Pharmaceuticals | Travel · 2025-11-03 | Crexont | $76 |
| Amneal Pharmaceuticals | Travel · 2025-11-03 | Crexont | $857 |
| MDD US Operations | Travel · 2025-10-30 | None | $360 |
| MDD US Operations | Honoraria · 2025-10-30 | None | $5,780 |
| MDD US Operations | Travel · 2025-10-30 | None | $127 |
| MDD US Operations | Travel · 2025-10-30 | None | $38 |
| MDD US Operations | Travel · 2025-10-30 | None | $107 |
| MDD US Operations | Travel · 2025-10-30 | None | $44 |
| MDD US Operations | Meals · 2025-10-30 | None | $19 |
| Amneal Pharmaceuticals | Travel · 2025-10-25 | Crexont | $175 |
| Abbvie | Travel · 2025-10-16 | Vyalev | $262 |
| Abbvie | Travel · 2025-10-16 | Vyalev | $89 |
| Abbvie | Travel · 2025-10-16 | Vyalev | $8 |
| Abbvie | Travel · 2025-10-16 | Vyalev | $626 |
| Abbvie | Meals · 2025-10-16 | Vyalev | $125 |
| Abbvie | Travel · 2025-10-16 | Vyalev | $69 |
| ACADIA Pharmaceuticals | Meals · 2025-10-14 | Nuplazid | $21 |
| Neurocrine BioSciences | Meals · 2025-10-08 | Ingrezza | $63 |
| Neurocrine BioSciences | Meals · 2025-10-06 | Ingrezza | $151 |
| Teva Pharmaceuticals USA | Meals · 2025-10-06 | Austedo Xr | $9 |
| MDD US Operations | Meals · 2025-10-05 | None | $93 |
| Neurocrine BioSciences | Meals · 2025-10-05 | Ingrezza | $25 |
| Abbvie | Paid to speak or teach · 2025-10-02 | Vyalev | $4,550 |
| Teva Pharmaceuticals USA | Education · 2025-09-26 | None | $99 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-09-26 | Austedo Xr | $3,190 |
| Teva Pharmaceuticals USA | Meals · 2025-09-26 | Austedo Xr | $3 |
| Teva Pharmaceuticals USA | Meals · 2025-09-26 | Austedo Xr | $10 |
| Teva Pharmaceuticals USA | Meals · 2025-09-26 | Austedo Xr | $18 |
| Amneal Pharmaceuticals | Honoraria · 2025-09-25 | Crexont | $4,973 |
| MDD US Operations | Honoraria · 2025-09-25 | None | $5,780 |
| MDD US Operations | Travel · 2025-09-25 | None | $29 |
| MDD US Operations | Travel · 2025-09-25 | None | $59 |
| MDD US Operations | Travel · 2025-09-25 | None | $38 |
| MDD US Operations | Travel · 2025-09-25 | None | $112 |
| MDD US Operations | Travel · 2025-09-25 | None | $274 |
| MDD US Operations | Travel · 2025-09-25 | None | $143 |
| Amneal Pharmaceuticals | Meals · 2025-09-22 | Crexont | $29 |
| Amneal Pharmaceuticals | Travel · 2025-09-22 | Crexont | $76 |
| Amneal Pharmaceuticals | Travel · 2025-09-22 | Crexont | $315 |
| Cala Health | Consulting · 2025-09-22 | Cala Kiq | $2,700 |
| Amneal Pharmaceuticals | Travel · 2025-09-20 | Crexont | $329 |
| Amneal Pharmaceuticals | Meals · 2025-09-19 | Crexont | $97 |
| Neurocrine BioSciences | Consulting · 2025-09-18 | None | $2,925 |
| MDD US Operations | Meals · 2025-09-17 | None | $27 |
| Abbvie | Meals · 2025-09-16 | Vyalev | $111 |
| Abbvie | Travel · 2025-09-16 | Vyalev | $1,009 |
| MDD US Operations | Meals · 2025-09-04 | None | $33 |
| ACADIA Pharmaceuticals | Meals · 2025-09-04 | Nuplazid | $26 |
| Amneal Pharmaceuticals | Travel · 2025-08-27 | Crexont | $1,033 |
| MDD US Operations | Meals · 2025-08-26 | None | $39 |
| Teva Pharmaceuticals USA | Consulting · 2025-08-25 | Austedo Xr | $610 |
| Amneal Pharmaceuticals | Honoraria · 2025-08-22 | Crexont | $2,048 |
| Abbvie | Paid to speak or teach · 2025-08-21 | Vyalev | $3,738 |
| Abbvie | Travel · 2025-08-09 | Vyalev | $269 |
| Abbvie | Travel · 2025-08-09 | Vyalev | $333 |
| Abbvie | Travel · 2025-08-09 | Vyalev | $193 |
| Abbvie | Meals · 2025-08-09 | Vyalev | $58 |
| Abbvie | Meals · 2025-08-09 | Vyalev | $23 |
| Abbvie | Meals · 2025-08-09 | Vyalev | $67 |
| Abbvie | Meals · 2025-08-09 | Vyalev | $24 |
| Abbvie | Meals · 2025-08-08 | Vyalev | $150 |
| MDD US Operations | Meals · 2025-07-30 | None | $34 |
| MDD US Operations | Travel · 2025-07-30 | None | $201 |
| MDD US Operations | Travel · 2025-07-30 | None | $848 |
| MDD US Operations | Travel · 2025-07-30 | None | $61 |
| MDD US Operations | Travel · 2025-07-30 | None | $85 |
| MDD US Operations | Honoraria · 2025-07-30 | None | $5,780 |
| Ipsen Biopharmaceuticals | Meals · 2025-07-14 | Dysport | $10 |
| Amneal Pharmaceuticals | Travel · 2025-06-30 | Crexont | $248 |
| MDD US Operations | Meals · 2025-06-30 | None | $48 |
| MDD US Operations | Travel · 2025-06-30 | None | $769 |
| MDD US Operations | Travel · 2025-06-30 | None | $40 |
| MDD US Operations | Travel · 2025-06-30 | None | $89 |
| MDD US Operations | Travel · 2025-06-30 | None | $100 |
| MDD US Operations | Honoraria · 2025-06-30 | None | $5,780 |
| Abbvie | Travel · 2025-06-26 | None | $239 |
| Abbvie | Meals · 2025-06-26 | None | $39 |
| Abbvie | Travel · 2025-06-26 | None | $160 |
| Abbvie | Travel · 2025-06-26 | None | $381 |
| Abbvie | Consulting · 2025-06-26 | None | $3,600 |
| MDD US Operations | Meals · 2025-06-25 | None | $26 |
| MDD US Operations | Meals · 2025-06-20 | None | $15 |
| MDD US Operations | Travel · 2025-06-20 | None | $738 |
| MDD US Operations | Honoraria · 2025-06-20 | None | $5,780 |
| MDD US Operations | Travel · 2025-06-20 | None | $19 |
| MDD US Operations | Travel · 2025-06-20 | None | $845 |
| MDD US Operations | Travel · 2025-06-20 | None | $177 |
| Neurocrine BioSciences | Meals · 2025-06-17 | Ingrezza | $16 |
| MDD US Operations | Meals · 2025-06-12 | None | $8 |
| MDD US Operations | Meals · 2025-06-12 | None | $29 |
| MDD US Operations | Meals · 2025-06-12 | None | $44 |
| MDD US Operations | Travel · 2025-06-12 | None | $491 |
| MDD US Operations | Travel · 2025-06-12 | None | $24 |
| MDD US Operations | Travel · 2025-06-12 | None | $59 |
| MDD US Operations | Travel · 2025-06-12 | None | $38 |
| MDD US Operations | Honoraria · 2025-06-12 | None | $5,780 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-06-10 | Ingrezza | $3,250 |
| Neurocrine BioSciences | Meals · 2025-06-10 | Ingrezza | $130 |
| Neurocrine BioSciences | Travel · 2025-06-10 | Ingrezza | $128 |
| Neurocrine BioSciences | Travel · 2025-06-10 | Ingrezza | $114 |
| MDD US Operations | Meals · 2025-06-07 | None | $29 |
| MDD US Operations | Travel · 2025-06-07 | None | $193 |
| MDD US Operations | Honoraria · 2025-06-07 | None | $5,780 |
| MDD US Operations | Travel · 2025-06-07 | None | $933 |
| MDD US Operations | Travel · 2025-06-07 | None | $7 |
| MDD US Operations | Meals · 2025-06-07 | None | $22 |
| MDD US Operations | Travel · 2025-06-07 | None | $76 |
| MDD US Operations | Travel · 2025-06-07 | None | $27 |
| MDD US Operations | Travel · 2025-06-07 | None | $27 |
| Abbvie | Consulting · 2025-06-06 | None | $3,900 |
| Abbvie | Travel · 2025-06-06 | None | $126 |
| MDD US Operations | Honoraria · 2025-06-04 | None | $5,780 |
| MDD US Operations | Travel · 2025-06-04 | None | $571 |
| MDD US Operations | Travel · 2025-06-04 | None | $8 |
| MDD US Operations | Meals · 2025-06-04 | None | $44 |
| MDD US Operations | Travel · 2025-06-04 | None | $16 |
| MDD US Operations | Travel · 2025-06-04 | None | $13 |
| MDD US Operations | Travel · 2025-06-04 | None | $100 |
| MDD US Operations | Travel · 2025-06-04 | None | $76 |
| MDD US Operations | Travel · 2025-06-03 | None | $575 |
| MDD US Operations | Honoraria · 2025-06-03 | None | $2,890 |
| MDD US Operations | Honoraria · 2025-06-03 | None | $5,780 |
| MDD US Operations | Meals · 2025-06-03 | None | $122 |
| MDD US Operations | Meals · 2025-06-03 | None | $11 |
| MDD US Operations | Travel · 2025-06-03 | None | $107 |
| MDD US Operations | Travel · 2025-06-03 | None | $11 |
| MDD US Operations | Travel · 2025-06-03 | None | $130 |
| MDD US Operations | Travel · 2025-06-03 | None | $48 |
| Amneal Pharmaceuticals | Meals · 2025-05-30 | Rytary | $13 |
| Amneal Pharmaceuticals | Meals · 2025-05-21 | Rytary | $18 |
| Merz Pharmaceuticals | Paid to speak or teach · 2025-05-19 | Xeomin | $660 |
| Teva Pharmaceuticals USA | Meals · 2025-05-16 | Austedo Xr | $21 |
| Teva Pharmaceuticals USA | Meals · 2025-05-15 | Austedo Xr | $11 |
| Teva Pharmaceuticals USA | Travel · 2025-05-15 | Austedo Xr | $80 |
| Teva Pharmaceuticals USA | Travel · 2025-05-15 | Austedo Xr | $224 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-05-15 | Austedo Xr | $5,421 |
| Teva Pharmaceuticals USA | Meals · 2025-05-15 | Austedo Xr | $34 |
| Teva Pharmaceuticals USA | Travel · 2025-05-15 | Austedo Xr | $102 |
| Teva Pharmaceuticals USA | Meals · 2025-05-15 | Austedo Xr | $13 |
| Teva Pharmaceuticals USA | Meals · 2025-05-15 | Austedo Xr | $118 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-05-15 | Austedo Xr | $2,552 |
| Teva Pharmaceuticals USA | Travel · 2025-05-15 | Austedo Xr | $19 |
| Teva Pharmaceuticals USA | Travel · 2025-05-15 | Austedo Xr | $224 |
| Abbvie | Consulting · 2025-05-14 | None | $650 |
| Neurocrine BioSciences | Meals · 2025-05-09 | Ingrezza | $125 |
| Neurocrine BioSciences | Meals · 2025-05-08 | Ingrezza | $150 |
| Abbvie | Meals · 2025-05-07 | Vyalev | $132 |
| Amneal Pharmaceuticals | Meals · 2025-05-07 | Crexont | $37 |
| Abbvie | Meals · 2025-05-06 | None | $19 |
| Abbvie | Meals · 2025-05-06 | None | $62 |
| Abbvie | Meals · 2025-05-06 | None | $50 |
| Amneal Pharmaceuticals | Honoraria · 2025-05-02 | Crexont | $2,048 |
| Amneal Pharmaceuticals | Education · 2025-04-30 | Crexont | $1,170 |
| MDD US Operations | Travel · 2025-04-30 | None | $70 |
| MDD US Operations | Travel · 2025-04-30 | None | $34 |
| MDD US Operations | Travel · 2025-04-30 | None | $84 |
| MDD US Operations | Travel · 2025-04-30 | None | $64 |
| MDD US Operations | Travel · 2025-04-30 | None | $414 |
| MDD US Operations | Honoraria · 2025-04-30 | None | $5,780 |
| MDD US Operations | Meals · 2025-04-30 | None | $18 |
| Ipsen Biopharmaceuticals | Meals · 2025-04-24 | Dysport | $27 |
| MDD US Operations | Honoraria · 2025-04-21 | None | $4,420 |
| MDD US Operations | Meals · 2025-04-18 | None | $50 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-04-17 | Austedo Xr | $3,188 |
| Teva Pharmaceuticals USA | Meals · 2025-04-17 | Austedo Xr | $31 |
| MDD US Operations | Meals · 2025-04-15 | None | $16 |
| MDD US Operations | Travel · 2025-04-15 | None | $82 |
| MDD US Operations | Travel · 2025-04-15 | None | $52 |
| MDD US Operations | Travel · 2025-04-15 | None | $38 |
| MDD US Operations | Travel · 2025-04-15 | None | $157 |
| MDD US Operations | Honoraria · 2025-04-15 | None | $5,780 |
| MDD US Operations | Travel · 2025-04-15 | None | $16 |
| MDD US Operations | Meals · 2025-04-07 | None | $108 |
| Abbvie | Meals · 2025-04-06 | Vyalev | $8 |
| Neurocrine BioSciences | Meals · 2025-04-06 | Ingrezza | $95 |
| Ipsen Biopharmaceuticals | Meals · 2025-04-05 | Dysport | $47 |
| MDD US Operations | Honoraria · 2025-04-04 | None | $167 |
| MDD US Operations | Honoraria · 2025-04-04 | Apokyn | $167 |
| MDD US Operations | Honoraria · 2025-04-04 | Gocovri | $167 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-04-03 | Austedo Xr | $6,469 |
| MDD US Operations | Consulting · 2025-04-02 | None | $4,000 |
| MDD US Operations | Consulting · 2025-03-28 | None | $500 |
| MDD US Operations | Meals · 2025-03-28 | None | $145 |
| Merz Pharmaceuticals | Travel · 2025-03-27 | Inbrija | $58 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-03-26 | Ingrezza | $3,250 |
| Neurocrine BioSciences | Travel · 2025-03-26 | Ingrezza | $23 |
| Neurocrine BioSciences | Travel · 2025-03-26 | Ingrezza | $16 |
| Neurocrine BioSciences | Consulting · 2025-03-25 | Ingrezza | $6,750 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-03-21 | Austedo Xr | $4,144 |
| Teva Pharmaceuticals USA | Meals · 2025-03-21 | Austedo Xr | $26 |
| Teva Pharmaceuticals USA | Travel · 2025-03-21 | Austedo Xr | $272 |
| Abbvie | Meals · 2025-03-20 | Vyalev | $11 |
| MDD US Operations | Honoraria · 2025-03-20 | None | $1,530 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-03-20 | Austedo Xr | $4,144 |
| Teva Pharmaceuticals USA | Meals · 2025-03-20 | Austedo Xr | $33 |
| Teva Pharmaceuticals USA | Travel · 2025-03-20 | Austedo Xr | $277 |
| MDD US Operations | Consulting · 2025-03-19 | None | $1,000 |
| Teva Pharmaceuticals USA | Meals · 2025-03-18 | Austedo Xr | $125 |
| Teva Pharmaceuticals USA | Travel · 2025-03-18 | Austedo Xr | $981 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-03-18 | Austedo Xr | $4,144 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-03-13 | Ingrezza | $4,000 |
| Neurocrine BioSciences | Travel · 2025-03-13 | Ingrezza | $215 |
| Neurocrine BioSciences | Travel · 2025-03-13 | Ingrezza | $168 |
| Merz Pharmaceuticals | Meals · 2025-03-08 | Inbrija | $71 |
| Merz Pharmaceuticals | Meals · 2025-03-08 | Inbrija | $21 |
| Merz Pharmaceuticals | Meals · 2025-03-08 | Inbrija | $41 |
| Merz Pharmaceuticals | Meals · 2025-03-08 | Inbrija | $25 |
| Merz Pharmaceuticals | Paid to speak or teach · 2025-03-08 | Inbrija | $9,240 |
| Merz Pharmaceuticals | Travel · 2025-03-07 | Inbrija | $184 |
| Neurocrine BioSciences | Travel · 2025-03-07 | Ingrezza | $74 |
| Teva Pharmaceuticals USA | Travel · 2025-03-07 | Austedo Xr | $39 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-03-07 | Austedo Xr | $3,188 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-03-06 | Austedo Xr | $3,188 |
| Teva Pharmaceuticals USA | Meals · 2025-03-06 | Austedo Xr | $38 |
| Teva Pharmaceuticals USA | Meals · 2025-03-06 | Austedo Xr | $124 |
| MDD US Operations | Honoraria · 2025-03-05 | Gocovri | $4,420 |
| Neurocrine BioSciences | Travel · 2025-03-01 | Ingrezza | $243 |
| Neurocrine BioSciences | Meals · 2025-03-01 | Ingrezza | $50 |
| Neurocrine BioSciences | Meals · 2025-03-01 | Ingrezza | $44 |
| Neurocrine BioSciences | Travel · 2025-03-01 | Ingrezza | $36 |
| Neurocrine BioSciences | Travel · 2025-03-01 | Ingrezza | $25 |
| Neurocrine BioSciences | Meals · 2025-03-01 | Ingrezza | $18 |
| Neurocrine BioSciences | Meals · 2025-03-01 | Ingrezza | $9 |
| Neurocrine BioSciences | Meals · 2025-03-01 | Ingrezza | $6 |
| Neurocrine BioSciences | Travel · 2025-02-28 | Ingrezza | $273 |
| Neurocrine BioSciences | Travel · 2025-02-28 | Ingrezza | $173 |
| Neurocrine BioSciences | Meals · 2025-02-28 | Ingrezza | $159 |
| ACADIA Pharmaceuticals | Meals · 2025-02-25 | Nuplazid | $25 |
| Amneal Pharmaceuticals | Honoraria · 2025-02-24 | Crexont | $2,048 |
| MDD US Operations | Consulting · 2025-02-24 | None | $1,000 |
| MDD US Operations | Meals · 2025-02-20 | None | $32 |
| Merz Pharmaceuticals | Travel · 2025-02-17 | Inbrija | $491 |
| Amneal Pharmaceuticals | Meals · 2025-02-14 | Rytary | $7 |
| MDD US Operations | Meals · 2025-02-11 | Apokyn | $22 |
| MDD US Operations | Travel · 2025-02-11 | Apokyn | $24 |
| MDD US Operations | Travel · 2025-02-11 | Apokyn | $38 |
| MDD US Operations | Travel · 2025-02-11 | Apokyn | $29 |
| MDD US Operations | Travel · 2025-02-11 | Apokyn | $177 |
| MDD US Operations | Honoraria · 2025-02-11 | Apokyn | $5,780 |
| MDD US Operations | Travel · 2025-01-31 | None | $722 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-01-27 | Ingrezza | $3,150 |
| Neurocrine BioSciences | Meals · 2025-01-25 | Ingrezza | $32 |
| Neurocrine BioSciences | Meals · 2025-01-25 | Ingrezza | $2 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-01-24 | Ingrezza | $3,600 |
| Neurocrine BioSciences | Travel · 2025-01-24 | Ingrezza | $203 |
| Neurocrine BioSciences | Travel · 2025-01-24 | Ingrezza | $156 |
| Neurocrine BioSciences | Meals · 2025-01-24 | Ingrezza | $1 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-01-22 | Ingrezza | $4,275 |
| Neurocrine BioSciences | Travel · 2025-01-22 | Ingrezza | $320 |
| Neurocrine BioSciences | Travel · 2025-01-22 | Ingrezza | $157 |
| Neurocrine BioSciences | Meals · 2025-01-22 | Ingrezza | $138 |
| Neurocrine BioSciences | Travel · 2025-01-22 | Ingrezza | $94 |
| Neurocrine BioSciences | Travel · 2025-01-22 | Ingrezza | $63 |
| Neurocrine BioSciences | Travel · 2025-01-22 | Ingrezza | $62 |
| Teva Pharmaceuticals USA | Paid to speak or teach · 2025-01-16 | Austedo Xr | $3,190 |
| Teva Pharmaceuticals USA | Travel · 2025-01-16 | Austedo Xr | $119 |
| Neurocrine BioSciences | Meals · 2025-01-13 | Ingrezza | $24 |
| MDD US Operations | Consulting · 2025-01-10 | None | $6,000 |
| MDD US Operations | Travel · 2025-01-10 | None | $695 |
| MDD US Operations | Travel · 2025-01-10 | None | $215 |
| MDD US Operations | Travel · 2025-01-10 | None | $312 |
| MDD US Operations | Meals · 2025-01-10 | None | $18 |
| MDD US Operations | Travel · 2025-01-10 | None | $76 |
| MDD US Operations | Travel · 2025-01-10 | None | $16 |
| MDD US Operations | Meals · 2025-01-10 | None | $95 |
| MDD US Operations | Meals · 2025-01-10 | None | $122 |
| MDD US Operations | Meals · 2025-01-10 | None | $31 |
| MDD US Operations | Meals · 2025-01-10 | None | $73 |
| MDD US Operations | Meals · 2025-01-10 | None | $43 |
| Amneal Pharmaceuticals | Meals · 2025-01-09 | Rytary | $7 |
| MDD US Operations | Travel · 2025-01-09 | None | $305 |
| Abbvie | Meals · 2025-01-02 | Vyalev | $16 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $184,885
| Neurocrine Biosciences | Ingrezza | $61,129 | 73 payments
|
| MDD US Operations | Gocovri | $39,833 | 43 payments
|
| Amneal Pharmaceuticals | Crexont | $38,614 | 42 payments
|
| Kyowa Kirin | Nourianz | $15,302 | 12 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $11,089 | 16 payments
|
| Cala Health | Cala Kiq | $10,900 | 3 payments
|
| Abbvie | Vyalev | $4,610 | 7 payments
|
| Merz Pharmaceuticals | Xeomin | $2,524 | 6 payments
|
| Acorda Therapeutics | Inbrija | $742 | 2 payments
|
| Supernus Pharmaceuticals | None | $86 | 1 payment
|
| Revance Therapeutics | Daxi | $40 | 2 payments
|
| Otsuka America Pharmaceutical | Nuedexta | $17 | 1 payment
|
2023: $134,484
| MDD US Operations | Gocovri | $71,925 | 78 payments
|
| Neurocrine Biosciences | Ingrezza | $19,412 | 28 payments
|
| Amneal Pharmaceuticals | None | $16,775 | 4 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $10,328 | 10 payments
|
| Acorda Therapeutics | Inbrija | $9,176 | 9 payments
|
| Kyowa Kirin | Nourianz | $5,130 | 4 payments
|
| Merz Pharmaceuticals | Xeomin | $622 | 2 payments
|
| Medtronic | Percept PC Brainsense | $527 | 10 payments
|
| Cala Health | Cala Trio | $500 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $45 | 1 payment
|
| AbbVie | Duopa | $25 | 1 payment
|
| Pfizer | Comirnaty | $18 | 1 payment
|
2022: $163,426
| MDD US Operations | Gocovri | $52,854 | 66 payments
|
| Amneal Pharmaceuticals | Rytary | $37,912 | 32 payments
|
| Teva Pharmaceuticals USA | Austedo | $17,171 | 15 payments
|
| Neurocrine Biosciences | Ongentys | $12,346 | 17 payments
|
| Kyowa Kirin | Nourianz | $11,311 | 12 payments
|
| Abbvie | Duopa | $10,779 | 12 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $8,606 | 17 payments
|
| Cala Health | Cala Trio | $8,290 | 12 payments
|
| Acorda Therapeutics | Inbrija | $3,784 | 6 payments
|
| Abbott Laboratories | Infinity | $169 | 2 payments
|
| Boston Scientific | General - Dbs | $149 | 2 payments
|
| Supernus Pharmaceuticals | None | $38 | 1 payment
|
| Impel Pharmaceuticals | Trudhesa | $19 | 1 payment
|
2021: $171,067
| Amneal Pharmaceuticals | Rytary | $47,875 | 45 payments
|
| Acorda Therapeutics | Inbrija | $28,274 | 27 payments
|
| Teva Pharmaceuticals USA | Austedo | $21,476 | 15 payments
|
| Kyowa Kirin | Nourianz | $20,173 | 17 payments
|
| AbbVie | Duopa | $16,551 | 12 payments
|
| Adamas Pharmaceuticals | Gocovri | $16,095 | 13 payments
|
| MDD US Operations | Apokyn | $11,264 | 13 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $3,540 | 6 payments
|
| Sunovion Pharmaceuticals | Kynmobi | $3,148 | 8 payments
|
| Lundbeck | Northera | $2,600 | 1 payment
|
| Ucb | Neupro | $29 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $26 | 1 payment
|
| Boston Scientific | Vercise | $16 | 1 payment
|
2020: $140,565
| Amneal Pharmaceuticals | Rytary | $34,907 | 33 payments
|
| Acorda Therapeutics | Inbrija | $20,034 | 24 payments
|
| US WorldMeds | Apokyn | $15,790 | 27 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $14,596 | 17 payments
|
| Adamas Pharmaceuticals | Gocovri | $12,843 | 15 payments
|
| AbbVie | Duopa | $11,507 | 15 payments
|
| Lundbeck | Northera | $10,142 | 11 payments
|
| Teva Pharmaceuticals USA | Austedo | $8,168 | 4 payments
|
| Kyowa Kirin | Nourianz | $8,160 | 10 payments
|
| Sunovion Pharmaceuticals | Kynmobi | $4,128 | 7 payments
|
| Medtronic USA | Activa | $128 | 2 payments
|
| Boston Scientific | General - Dbs | $109 | 1 payment
|
| Catalyst Pharmaceuticals | Firdapse | $28 | 1 payment
|
| Allergan | Ubrelvy | $24 | 1 payment
|
2019: $325,131
| US WorldMeds | Apokyn | $97,435 | 173 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $56,425 | 72 payments
|
| Amneal Pharmaceuticals | Rytary | $52,957 | 53 payments
|
| Acorda Therapeutics | Inbrija | $36,637 | 43 payments
|
| Adamas Pharmaceuticals | Gocovri | $32,836 | 32 payments
|
| Lundbeck | Northera | $26,095 | 35 payments
|
| AbbVie | Duopa | $14,062 | 23 payments
|
| Teva Pharmaceuticals USA | Austedo | $7,682 | 15 payments
|
| Medtronic USA | None | $780 | 1 payment
|
| Ucb | Neupro | $74 | 2 payments
|
| Bausch Health US | Migranal | $44 | 2 payments
|
| Boston Scientific | Vercise | $39 | 1 payment
|
| Avanir Pharmaceuticals | Nuedexta | $30 | 1 payment
|
| Novartis Pharmaceuticals | Aimovig | $18 | 1 payment
|
| Kyowa Kirin | Nourianz | $18 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Amneal Pharmaceuticals LLC · Crexont · 2025 | This clinician | $136,485 |
| H. Lundbeck A S · A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension To Assess Sustained Effects of Droxidopa Therapy · 2022 | Their institution | $40,150 |
| ABBVIE INC. · Real-World Study of Abbv-951 Subcutaneous Infusion To Assess Change in Disease Activity in Adult Participants With Parkinson S Disease · 2025 | Their institution | $31,104 |
| Integrative Research Laboratories Sweden AB · Irl790c005 · 2022 | Their institution | $15,894 |
| Integrative Research Laboratories Sweden AB · Irl790c005 · 2023 | Their institution | $12,871 |
| ABBVIE INC. · A Global Real World Evidence Study on the Long Term Effectiveness of Abbv-951 in Advanced Parkinsons Disease · 2025 | Their institution | $11,500 |
| ABBVIE INC. · P22-487 - Real-World Study of Abbv-951 Subcutaneous Infusion To Assess Change in Disease Activity in Adult Participants With Parkinson S Disease · 2025 | Their institution | $10,500 |
| ACADIA Pharmaceuticals Inc · Nuplazid · 2022 | Their institution | $7,500 |
| Neurocrine BioSciences, Inc. · Opicapone Treatment Initiation Open-Label Study · 2022 | Their institution | $5,527 |
| ACADIA Pharmaceuticals Inc · Aca 16-Cac-0001 · 2020 | This clinician | $4,500 |
| H. Lundbeck A S · Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension (Restore) · 2023 | Their institution | $4,096 |
| ACADIA Pharmaceuticals Inc · Aca 16-Cac-0001 · 2019 | This clinician | $4,000 |
| Amneal Pharmaceuticals LLC · Crexont · 2024 | This clinician | $1,155 |
Professional record
- NPI
- 1841292455
- Licence
- PA MD426353
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 675 Almanor Ave, Sunnyvale, CA, 94085
- NPI first listed
- 2005-08-12
- NPI last updated
- 2023-03-07
This is when the NPI record was last certified, not a medical board exam.